Literature DB >> 7890013

Persistence of counter-regulatory abnormalities in insulin-dependent diabetes mellitus after pancreas transplantation.

A Battezzati1, L Luzi, G Perseghin, E Bianchi, D Spotti, A Secchi, S Vergani, V Di Carlo, G Pozza.   

Abstract

Conventional insulin therapy does not correct the counter-regulatory abnormalities of insulin-dependent diabetes mellitus. Pancreas transplantation is an alternative therapy that restores the endogenous insulin secretion in diabetes. In this study, the effects of segmental pancreas transplantation on counter-regulation to mild hypoglycaemia were evaluated. Glucose kinetics and the counter-regulatory hormonal responses were assessed in eight insulin-dependent diabetics with end-stage renal failure who had received pancreas and kidney transplantation 1 year previously, seven diabetic uraemic subjects (candidates for combined transplantation), five patients with chronic uveitis on immunosuppressive therapy comparable to pancreas recipients and 10 normal subjects. Insulin (0.3 mU kg-1 min-1) was infused for 2 h to induce mild hypoglycaemia (plasma glucose 3.2-3.5 mmol l-1) and exogenous glucose was infused as required to prevent any glucose decrease below 3.1 mmol l-1. After transplantation, two of eight recipients had hypoglycaemic episodes reported in their medical records. During the study, hepatic glucose production was rapidly suppressed in the controls and in the patients on immunosuppression (-80 +/- 7 and -54 +/- 7%, P < 0.001 vs. basal), and rebounded to the baseline values within 1 h (-3 +/- 1 and -6 +/- 2%, P = NS vs. basal). The transplant recipients had similar suppression in the first hour (-88 +/- 8%, P < 0.001 vs. basal), but the suppression persisted in the second hour (-69 +/- 11%, P < 0.001 vs. basal) indicating a lack of glucose counter-regulatory response.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7890013     DOI: 10.1111/j.1365-2362.1994.tb01072.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Regulation of glucose homeostasis in humans with denervated livers.

Authors:  G Perseghin; E Regalia; A Battezzati; S Vergani; A Pulvirenti; I Terruzzi; D Baratti; F Bozzetti; V Mazzaferro; L Luzi
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantation.

Authors:  Luisa M Rodríguez; Richard J Knight; Rubina A Heptulla
Journal:  Diabetes Technol Ther       Date:  2010-05       Impact factor: 6.118

Review 3.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 4.  Recovery of endocrine function after islet and pancreas transplantation.

Authors:  Michael R Rickels
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

5.  Hypoglycemia following pancreas transplantation.

Authors:  Joy Shen; Jason Gaglia
Journal:  Curr Diab Rep       Date:  2008-08       Impact factor: 4.810

6.  Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus.

Authors:  L Luzi; B J Hering; C Socci; G Raptis; A Battezzati; I Terruzzi; L Falqui; H Brandhorst; D Brandhorst; E Regalia; E Brambilla; A Secchi; G Perseghin; P Maffi; E Bianchi; V Mazzaferro; L Gennari; V Di Carlo; K Federlin; G Pozza; R G Bretzel
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.